Nonacus

Nonacus focuses on liquid biopsy and

Next Generation Sequencing (NGS) technologies to improve cancer diagnosis,

offering hereditary cancer testing services and GALEAS Bladder, a sensitive,

non-invasive urine test for detection and monitoring.